The American Academy of Sleep Medicine (AASM) and former NFL offensive lineman Aaron Taylor have partnered to launch two new public service announcements (PSAs) urging television viewers to “Defend Your Sleep” by talking to a doctor about obstructive sleep apnea.

“Sleep apnea afflicts nearly 30 million American adults, and most of them remain untreated, increasing their risk of cardiovascular disease, hypertension, stroke, and type 2 diabetes,” says AASM president Douglas B. Kirsch, MD, in a release. “With Aaron’s help, we hope to further educate the community about the warning signs of sleep apnea and demonstrate that many of the damaging effects of the disease can be stopped, and even reversed, through diagnosis and treatment by the sleep team at an accredited sleep center.”

For Taylor, sleep apnea is personal. An avid snorer since he was in high school, he found himself with a lack of energy that began to affect his family life and performance on the field. However, it was not until two friends with sleep apnea died prematurely that he sought help from his doctor.

“At the end

Jazz Pharmaceuticals plc has submitted a marketing authorization application (MAA) to the European Medicines Agency for solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor, as a treatment to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with narcolepsy (with or without cataplexy) or obstructive sleep apnea (OSA).

“Excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea can be debilitating for patients and challenging for the medical community to diagnose and treat,” says Jed Black, MD, senior vice president, Sleep and CNS Medicine at Jazz Pharmaceuticals and adjunct professor, Stanford University Medical Center, Stanford Center for Sleep Sciences and Medicine, in a release. “Jazz is committed to addressing unmet needs in sleep medicine by delivering meaningful treatment options.”

Yves Dauvilliers, MD, PhD, head of sleep and wake Disorders at the University Hospital of Montpellier, France, says, “In the European Union, there is no approved treatment for people with excessive daytime sleepiness associated with obstructive sleep apnea, and people with excessive daytime sleepiness due to narcolepsy may benefit from the availability of new treatment options. As the sleep

Compare 16 custom oral appliances for obstructive sleep apnea side-by-side. Click on the thumbnail or “OralAppliances1018” to open the guide at a legible size or print it. The guide compares features such as warranty, indications, materials, Medicare compliance, how it works, fitting, adjustment, connection between upper and lower sections, and peer-reviewed studies for the following products: Airway Management Inc dreamTAP, Dream Systems LLC OASYS with Nasal Dilators (Optional Tongue Repositioners), DynaFlex Milled Dorsal, DynaFlex Milled Herbst, Glidewell Laboratories Silent Nite sl, Great Lakes Orthodontics Ltd Telescopic Sleep Herbst Appliance in Hard Acrylic, Luco Hybrid OSA Appliance Inc The Luco Hybrid OSA Appliance, OravanOSA Oravan Herbst, Oventus O₂ Vent W, Panthera Dental Panthera D-SAD (Digital – Sleep Apnea Device), ProSomnus [CA] Continuous Advancement Sleep and Snore Device, ProSomnus [IA] Sleep and Snore Device with Monogram Customization, Quiesco Health The Silencer with Haelstrom Hinge, SML-Space Maintainers Laboratories Clear Sleep Appliance, SomnoMed SomnoDent Fusion, and Whole You Inc Respire Blue EF+.

A version of this comparison guide published in Sleep Review‘s October 2018 issue. If your company is missing,

Built-in medical device power and accessories like inverters help drivers of commercial vehicles who have sleep apnea better manage competing electrical demands.

By Lisa Spear

When truckers are on the road, they often have to balance the competing electrical demands of their medical devices with those of all the household appliances that keep them comfortable. More than a decade ago, truck driver Bob Stanton regularly had trouble starting his truck in the morning after running his CPAP machine off of the vehicle’s batteries overnight, but now he runs his ResMed AirSense 10 off a diesel auxiliary power unit (APU), essentially a small engine attached to the side of his truck, and it works just fine.

“Part of the reasonable accommodations my employer makes for sleep apnea is keeping me assigned to a truck that has an APU,” Stanton says.

He no longer has a problem keeping his CPAP powered through the night, but this is a change from when he was first diagnosed and his former employer didn’t want to make the $10,000 investment to install an APU. That was